Update on Immunohistochemistry for the Diagnosis of Lung Cancer

被引：106

作者：

Inamura, Kentaro ^{[1
]}

机构：

[1] Japanese Fdn Canc Res, Canc Inst, Div Pathol, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan

来源：

CANCERS | 2018年 / 10卷 / 03期

关键词：

immune checkpoint; immunostaining; INSM1; morphology; non-small cell lung carcinoma (NSCLC); pathology; thoracic tumor; small cell lung carcinoma (SCLC); tyrosine kinase; WHO classification; NUT MIDLINE CARCINOMA; GROWTH-FACTOR RECEPTOR; LIGAND; EXPRESSION; PREVIOUSLY TREATED PATIENTS; PD-L1; IMMUNOHISTOCHEMISTRY; CELL-CARCINOMA; OPEN-LABEL; ROS1; INTERNATIONAL-ASSOCIATION; BAP1;

D O I：

10.3390/cancers10030072

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Immunohistochemistry is a widely available technique that is less challenging and can provide clinically meaningful results quickly and cost-efficiently in comparison with other techniques. In addition, immunohistochemistry allows for the evaluation of cellular localization of proteins in the context of tumor structure. In an era of precision medicine, pathologists are required to classify lung cancer into specific subtypes and assess biomarkers relevant to molecular-targeted therapies. This review summarizes the hot topics of immunohistochemistry in lung cancer, including (i) adenocarcinoma vs squamous cell carcinoma; (ii) neuroendocrine markers; (iii) ALK, ROS1, and EGFR; (iv) PD-L1 (CD274); (v) lung carcinoma vs malignant mesothelioma; and (vi) NUT carcinoma. Major pitfalls in evaluating immunohistochemical results are also described.

引用

页数：15

共 108 条

[61] Comparison of Thyroid Transcription Factor-1 Expression by 2 Monoclonal Antibodies in Pulmonary and Nonpulmonary Primary Tumors [J].

Matoso, Andres ;

Singh, Kamaljeet ;

Jacob, Rafik ;

Greaves, Wesley O. ;

Tavares, Rosemarie ;

Noble, Lelia ;

Resnick, Murray B. ;

DeLellis, Ronald A. ;

Wang, Li J. .

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2010, 18 (02) :142-149

[62] On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas [J].

Mescam-Mancini, Lenaig ;

Lantuejoul, Sylvie ;

Moro-Sibilot, Denis ;

Rouquette, Isabelle ;

Souquet, Pierre-Jean ;

Audigier-Valette, Clarisse ;

Sabourin, Jean-Christophe ;

Decroisette, Chantal ;

Sakhri, Linda ;

Brambilla, Elisabeth ;

McLeer-Florin, Anne .

LUNG CANCER, 2014, 83 (02) :168-173

[63] The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs [J].

Micke, Patrick ;

Mattsson, Johanna Sofia Margareta ;

Djureinovic, Dijana ;

Nodin, Bjorn ;

Jirstrom, Karin ;

Tran, Lena ;

Jonsson, Per ;

Planck, Maria ;

Botling, Johan ;

Brunnstrom, Hans .

JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (06) :862-872

[64] Immunohistochemistry for predictive biomarkers in non-small cell lung cancer [J].

Mino-Kenudson, Mari .

TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 (05) :570-587

[65] A Study of ΔNp63 Expression in Lung Non-Small Cell Carcinomas [J].

Nonaka, Daisuke .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (06) :895-899

[66] Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer [J].

Peifer, Martin ;

Fernandez-Cuesta, Lynnette ;

Sos, Martin L. ;

George, Julie ;

Seidel, Danila ;

Kasper, Lawryn H. ;

Plenker, Dennis ;

Leenders, Frauke ;

Sun, Ruping ;

Zander, Thomas ;

Menon, Roopika ;

Koker, Mirjam ;

Dahmen, Ilona ;

Mueller, Christian ;

Di Cerbo, Vincenzo ;

Schildhaus, Hans-Ulrich ;

Altmueller, Janine ;

Baessmann, Ingelore ;

Becker, Christian ;

de Wilde, Bram ;

Vandesompele, Jo ;

Boehm, Diana ;

Ansen, Sascha ;

Gabler, Franziska ;

Wilkening, Ines ;

Heynck, Stefanie ;

Heuckmann, Johannes M. ;

Lu, Xin ;

Carter, Scott L. ;

Cibulskis, Kristian ;

Banerji, Shantanu ;

Getz, Gad ;

Park, Kwon-Sik ;

Rauh, Daniel ;

Gruetter, Christian ;

Fischer, Matthias ;

Pasqualucci, Laura ;

Wright, Gavin ;

Wainer, Zoe ;

Russell, Prudence ;

Petersen, Iver ;

Chen, Yuan ;

Stoelben, Erich ;

Ludwig, Corinna ;

Schnabel, Philipp ;

Hoffmann, Hans ;

Muley, Thomas ;

Brockmann, Michael ;

Engel-Riedel, Walburga ;

Muscarella, Lucia A. .

NATURE GENETICS, 2012, 44 (10) :1104-+

[67] A Phase III Study of Durvalumab (MEDI4736) With or Without Tremelimumab for Previously Treated Patients With Advanced NSCLC: Rationale and Protocol Design of the ARCTIC Study [J].

Planchard, David ;

Yokoi, Takashi ;

McCleod, Michael J. ;

Fischer, Juergen R. ;

Kim, Young-Chul ;

Ballas, Marc ;

Shi, Kelvin ;

Soria, Jean-Charles .

CLINICAL LUNG CANCER, 2016, 17 (03) :232-+

[68] Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression [J].

Polley, Eric ;

Kunkel, Mark ;

Evans, David ;

Silvers, Thomas ;

Delosh, Rene ;

Laudeman, Julie ;

Ogle, Chad ;

Reinhart, Russell ;

Selby, Michael ;

Connelly, John ;

Harris, Erik ;

Fer, Nicole ;

Sonkin, Dmitriy ;

Kaur, Gurmeet ;

Monks, Anne ;

Malik, Shakun ;

Morris, Joel ;

Teicher, Beverly A. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (10)

[69] Agreement between Programmed Cell Death Ligand-1 Diagnostic Assays across Multiple Protein Expression Cutoffs in Non-Small Cell Lung Cancer [J].

Ratcliffe, Marianne J. ;

Sharpe, Alan ;

Midha, Anita ;

Barker, Craig ;

Scott, Marietta ;

Scorer, Paul ;

Al-Masri, Hytham ;

Rebelatto, Marlon C. ;

Walker, Jill .

CLINICAL CANCER RESEARCH, 2017, 23 (14) :3585-3591

[70] Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens [J].

Rekhtman, Natasha ;

Ang, Daphne C. ;

Sima, Camelia S. ;

Travis, William D. ;

Moreira, Andre L. .

MODERN PATHOLOGY, 2011, 24 (10) :1348-1359

← 2 3 4 5 6 7 8 9 10 11 →